Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model

MakaleAçık ErişimScopus SJRQ1
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Insomnia is a major global health issue, highlighting the need for treatments that are both effective and safe. Valerian extract, a traditional remedy for sleep problems, offers potential therapeutic options. This research examined the potential sleep-enhancing effects of VA (Valerian Pdr%2) in mice. The study evaluated sleep quality by comparing the impact of the VA extract against melatonin on brain activity, using electrocorticography (ECoG) to assess changes in brain waves. For this purpose, the study utilized two experimental models on BALB/c mice to explore the effects of caffeine-induced insomnia and pentobarbital-induced sleep. In the first model, 25 mice were assigned to five groups to test the effects of caffeine (caffeine, 7.5 mg/kg i.p) alone, caffeine with melatonin (2 mg/kg), or caffeine with different doses of valerian extract (100 or 300 mg/kg) given orally on brain activity, assessed via electrocorticography (ECoG) and further analyses on the receptor proteins and neurotransmitters. In the second model, a different set of 25 mice were divided into five groups to examine the impact of pentobarbital (42 mg/kg) alone, with melatonin, or with the valerian extract on sleep induction, observing the effects 45 min after administration. The study found that ECoG frequencies were lower in groups treated with melatonin and two doses of valerian extract (100 and 300 mg/kg), with 300 mg/kg showing the most significant effect in reducing frequencies compared to the caffeine control group, indicating enhanced sleep quality (p < 0.05). This was supported by increased levels of serotonin, melatonin, and dopamine and higher levels of certain brain receptors in the melatonin and valerian extract groups (p < 0.05). Modulatory efficacy for the apoptotic markers in the brain was also noted (p < 0.05). Additionally, melatonin and both doses of VA increased sleep duration and reduced sleep onset time compared to the pentobarbital control, which was particularly notable with high doses. In conclusion, the findings suggest that high doses (300 mg/kg) of valerian extract enhance both the quantity and quality of sleep through the GABAergic pathway and effectively increase sleep duration while reducing the time to fall asleep in a pentobarbital-induced sleep model in mice.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/munzur/1974Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3390/antiox13060657Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
19
OpenAlex
19
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorSahin, Kazim
dc.contributor.authorGencoglu, Hasan
dc.contributor.authorKorkusuz, Ahmet Kayhan
dc.contributor.authorOrhan, Cemal
dc.contributor.authorAldatmaz, İsmail Ertuğ
dc.contributor.authorErten, Fusun
dc.contributor.authorEr, Besir
dc.contributor.authorMorde, Abhijeet
dc.contributor.authorPadigaru, Muralidhara
dc.contributor.authorKilic, Ertugrul
dc.date.accessioned2026-10-28T14:54:46.905812664Z
dc.date.available2026-10-28T14:54:46.905812664Z
dc.date.issued2024
dc.description.abstractInsomnia is a major global health issue, highlighting the need for treatments that are both effective and safe. Valerian extract, a traditional remedy for sleep problems, offers potential therapeutic options. This research examined the potential sleep-enhancing effects of VA (Valerian Pdr%2) in mice. The study evaluated sleep quality by comparing the impact of the VA extract against melatonin on brain activity, using electrocorticography (ECoG) to assess changes in brain waves. For this purpose, the study utilized two experimental models on BALB/c mice to explore the effects of caffeine-induced insomnia and pentobarbital-induced sleep. In the first model, 25 mice were assigned to five groups to test the effects of caffeine (caffeine, 7.5 mg/kg i.p) alone, caffeine with melatonin (2 mg/kg), or caffeine with different doses of valerian extract (100 or 300 mg/kg) given orally on brain activity, assessed via electrocorticography (ECoG) and further analyses on the receptor proteins and neurotransmitters. In the second model, a different set of 25 mice were divided into five groups to examine the impact of pentobarbital (42 mg/kg) alone, with melatonin, or with the valerian extract on sleep induction, observing the effects 45 min after administration. The study found that ECoG frequencies were lower in groups treated with melatonin and two doses of valerian extract (100 and 300 mg/kg), with 300 mg/kg showing the most significant effect in reducing frequencies compared to the caffeine control group, indicating enhanced sleep quality (p < 0.05). This was supported by increased levels of serotonin, melatonin, and dopamine and higher levels of certain brain receptors in the melatonin and valerian extract groups (p < 0.05). Modulatory efficacy for the apoptotic markers in the brain was also noted (p < 0.05). Additionally, melatonin and both doses of VA increased sleep duration and reduced sleep onset time compared to the pentobarbital control, which was particularly notable with high doses. In conclusion, the findings suggest that high doses (300 mg/kg) of valerian extract enhance both the quantity and quality of sleep through the GABAergic pathway and effectively increase sleep duration while reducing the time to fall asleep in a pentobarbital-induced sleep model in mice.
dc.description.sponsorshipOmniActive Health Technologies
dc.description.sponsorshipTürkiye Bilimler Akademisi
dc.identifier.articlenumber657
dc.identifier.doi10.3390/antiox13060657
dc.identifier.eissn2076-3921
dc.identifier.issn2076-3921
dc.identifier.issue6
dc.identifier.pmcidPMC11200646
dc.identifier.pmid38929096
dc.identifier.scopus2-s2.0-85197868072
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/munzur/1974
dc.identifier.volume13
dc.identifier.wosWOS:001254922800001
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.ispartofAntioxidants
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectapoptosis
dc.subjectcaffeine
dc.subjectmelatonin
dc.subjectneurotransmitters
dc.subjectsleep disturbance
dc.subjectvalerian
dc.titleImpact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model
dc.typeArticle
rdl.citation.openalex19
rdl.citation.scopus19
rdl.departmentDepartment of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, 23119 Elazig, Türkiye
rdl.departmentDepartment of Biology, Faculty of Science, Firat University, 23119 Elazig, Türkiye
rdl.departmentDepartment of Physiology, School of Medicine, Istanbul Medipol University, 34810 Istanbul, Türkiye
rdl.departmentDepartment of Veterinary Science, Pertek Sakine Genc Vocational School, Munzur University, 62500 Tunceli, Türkiye
rdl.departmentResearch and Development, OmniActive Health Technologies, Mumbai 400013, India
rdl.departmentDepartment of Physiology, Faculty of Medicine, Istanbul Medeniyet University, 34700 Istanbul, Türkiye
rdl.oa.statusgold
rdl.oa.statusclosed
rdl.oa.statusgreen
rdl.oa.urlhttps://www.mdpi.com/2076-3921/13/6/657/pdf?version=1716816247
rdl.scopus.quartileQ1
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED